Đang chuẩn bị liên kết để tải về tài liệu:
HYBRIDOMA TECHNOLOGY FOR PRODUCTION OF MONOCLONAL ANTIBODIES

Không đóng trình duyệt đến khi xuất hiện nút TẢI XUỐNG

Hybridomas are cells that have been engineered to produce a desired antibody in large amounts. To produce monoclonal antibodies, Bcells are removed from the spleen of an animal that has been challenged with the relevant antigen. These B-cells are then fused with myeloma tumor cells that can grow indefinitely in culture (myeloma is a B-cell cancer). This fusion is performed by making the cell membranes more permeable. The fused hybrid cells (called hybridomas), being cancer cells, will multiply rapidly and indefinitely and will produce large amounts of the desired antibodies. They have to be selected and subsequently cloned by limiting dilution. Supplemental media containing Interleukin-6.

TÀI LIỆU LIÊN QUAN

Production of monoclonal antibodies specific for progesterone

Simple production and purification of monoclonal antibodies in serum free medium

Production of monoclonal antibodies specific for progesterone, estradiole by simultaneous injection of different steroids

Generation of monoclonal antibodies against native viral proteins using antigenexpressing mammalian cells for mouse immunization

HYBRIDOMA TECHNOLOGY FOR PRODUCTION OF MONOCLONAL ANTIBODIES
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.